ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia ; volume:40 ; number:S 01 ; year:2019 ; pages:S169-S172 ; 01
Indian journal of medical & paediatric oncology ; 40, Heft S 01 (2019), S169-S172, 01
- Contributor
-
Kakkar, Aanchal
Sharma, Bhavna
Das, Prasenjit
Jain, Siddharth
Dattagupta, Siddharth
Sood, Rita
- DOI
-
10.4103/ijmpo.ijmpo_153_17
- URN
-
urn:nbn:de:101:1-2021080512015434145970
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:04 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kakkar, Aanchal
- Sharma, Bhavna
- Das, Prasenjit
- Jain, Siddharth
- Dattagupta, Siddharth
- Sood, Rita
Other Objects (12)
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
Gastric fundal splenosis presenting as a stromal tumor and diagnosed by endoscopic ultrasound-guided SharkCore biopsy
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
Gastric fundal splenosis presenting as a stromal tumor and diagnosed by endoscopic ultrasound-guided SharkCore biopsy
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients
Gastric fundal splenosis presenting as a stromal tumor and diagnosed by endoscopic ultrasound-guided SharkCore biopsy
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center